Department of Pediatrics - Hematology/Oncology Research

Hematology/Oncology Research

The Division of Pediatric Hematology/Oncology has active research programs. These include clinical research and bench research.

Clinical Research Includes the Following:

  • The division participates as a full member of the Children's Oncology Group and the Dana Farber Cancer Institute leukemia consortium. Through participation in these cutting-edge clinical research programs our oncology patients can receive state-of-the-art cancer care.
  • Drs. Craig Mullen, and Lauren Bruckner have developed a clinical research program investigating the use of related haploidentical blood stem cell donors for patients who need a bone marrow transplant but lack a suitable donor.
  • Olle Jane Z. Sahler, M.D. conducts NIH sponsored research in the area of cognitive remediation of childhood cancer survivors.
  • Dr. David Korones and Dr. O. J. Sahler are developing a palliative care research program whose goal is to improve the care of children approaching the end of life.

Basic Science Research Includes the Following:

  • Dr. Jim Palis leads an interactive group of investigators focused on better understanding the cellular and molecular events underlying the emergence of the hematopoietic system in the mammalian embryo as well as the response of the bone marrow to clastogenic injury. More information
  • Dr. Craig Mullen has a research program that investigates the interaction between immune system in acute leukemia cells after allogeneic bone marrow transplantation. The goal of this research is to define the mechanism of graft versus leukemia effects and to determine if vaccine therapy or other immune therapies can reduce the risk of relapse after transplant.
  • Pediatric Hematology/Oncology Investigators & Research Interests